High-frequency gamma oscillations stimulate activity-dependent release of brain-derived neurotrophic factor (BDNF) from excitatory terminals, activating TrkB receptors on postsynaptic neurons to promote spine stabilization and prevent glutamate receptor internalization. This has the highest druggability potential given extensive TrkB agonist development programs. Critical barrier: BDNF does not cross the blood-brain barrier; systemic TrkB agonists must achieve high CNS penetration, which has historically been the failure mode.
Auto-built from this analysis's top knowledge-graph edges.
graph TD
excitation_inhibition_imb["excitation/inhibition imbalance"] -->|associated with| Early_Alzheimer_S_Disease["Early Alzheimer'S Disease"]
PV__interneuron_activatio["PV+ interneuron activation"] -->|associated with| excitation_inhibition_bal["excitation/inhibition balance"]
BDNF["BDNF"] -->|activates| TrkB_receptors["TrkB receptors"]
PV__interneuron_activatio_1["PV+ interneuron activation"] -->|causes| Memory_Improvements["Memory Improvements"]
BDNF_2["BDNF"] -->|regulates| gamma_entrainment_memory_["gamma entrainment memory benefits"]
sess_SRB_2026_04_28_h_bdb["sess_SRB-2026-04-28-h-bdbd2120_task_9aae8fc5"] -->|causal extracted| processed["processed"]
style excitation_inhibition_imb fill:#4fc3f7,stroke:#333,color:#000
style Early_Alzheimer_S_Disease fill:#ef5350,stroke:#333,color:#000
style PV__interneuron_activatio fill:#4fc3f7,stroke:#333,color:#000
style excitation_inhibition_bal fill:#81c784,stroke:#333,color:#000
style BDNF fill:#ce93d8,stroke:#333,color:#000
style TrkB_receptors fill:#4fc3f7,stroke:#333,color:#000
style PV__interneuron_activatio_1 fill:#4fc3f7,stroke:#333,color:#000
style Memory_Improvements fill:#4fc3f7,stroke:#333,color:#000
style BDNF_2 fill:#ce93d8,stroke:#333,color:#000
style gamma_entrainment_memory_ fill:#4fc3f7,stroke:#333,color:#000
style sess_SRB_2026_04_28_h_bdb fill:#4fc3f7,stroke:#333,color:#000
style processed fill:#4fc3f7,stroke:#333,color:#000No linked papers recorded for this hypothesis yet.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for BDNF (brain-derived neurotrophic factor); NTRK2 (TrkB); CREBBP.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF 5xFAD mice receive 40Hz gamma entrainment via optogenetic excitation of medial septum cholinergic neurons (100 pulses, 20ms each, 30 min/day) for 14 consecutive days, THEN hippocampal BDNF protein | ≥40% increase in hippocampal BDNF concentration; restoration of CA1 pyramidal neuron spine density to ≥95% of wild-type levels as measured by Golgi-Cox staining | — no observation — | pending | 0.70 |
| IF 40Hz gamma entrainment (same protocol as prediction 1) is co-administered with the selective TrkB antagonist ANA-12 (10mg/kg, i.p., 30 min pre-stimulation) in 5xFAD mice, THEN the gamma-induced inc | Spine density in the ANA-12 + gamma group statistically indistinguishable from vehicle-treated 5xFAD controls (p>0.05, two-way ANOVA with Tukey post-hoc); AMPAR | — no observation — | pending | 0.65 |